Sahakian, L.;                     Robinson, A.M.;                     Sahakian, L.;                     Stavely, R.;                     Kelley, M.R.;                     Nurgali, K.    
        APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules 2023, 13, 1569.
    https://doi.org/10.3390/biom13111569
    AMA Style
    
                                Sahakian L,                                 Robinson AM,                                 Sahakian L,                                 Stavely R,                                 Kelley MR,                                 Nurgali K.        
                APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules. 2023; 13(11):1569.
        https://doi.org/10.3390/biom13111569
    
    Chicago/Turabian Style
    
                                Sahakian, Lauren,                                 Ainsley M. Robinson,                                 Linda Sahakian,                                 Rhian Stavely,                                 Mark R. Kelley,                                 and Kulmira Nurgali.        
                2023. "APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease" Biomolecules 13, no. 11: 1569.
        https://doi.org/10.3390/biom13111569
    
    APA Style
    
                                Sahakian, L.,                                 Robinson, A. M.,                                 Sahakian, L.,                                 Stavely, R.,                                 Kelley, M. R.,                                 & Nurgali, K.        
        
        (2023). APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease. Biomolecules, 13(11), 1569.
        https://doi.org/10.3390/biom13111569